Please assess the completion status of the following clinical trial:

Trial Title: Efficacy and Safety Trial of the ALK HDM Tablet in House Dust Mite Allergic Subjects

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2/PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* A history of house dust mite induced asthma~* Use of inhaled corticosteroids (ICS)~* Positive skin prick test to house dust mites~* Positive specific IgE to house dust mites~Exclusion Criteria:~* FEV1 lower than 70%

- Gender: ALL
- Minimum Age: 14 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).